Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI896

Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease.

T Lin, T Brunner, B Tietz, J Madsen, E Bonfoco, M Reaves, M Huflejt, and D R Green

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Lin, T. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Brunner, T. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Tietz, B. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Madsen, J. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Bonfoco, E. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Reaves, M. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Huflejt, M. in: JCI | PubMed | Google Scholar

Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA. tesu lin@liai.org

Find articles by Green, D. in: JCI | PubMed | Google Scholar

Published February 1, 1998 - More info

Published in Volume 101, Issue 3 on February 1, 1998
J Clin Invest. 1998;101(3):570–577. https://doi.org/10.1172/JCI896.
© 1998 The American Society for Clinical Investigation
Published February 1, 1998 - Version history
View PDF
Abstract

In vitro studies have demonstrated that intestinal intraepithelial lymphocytes (IEL) are constitutively cytotoxic; however, the mechanism and target of their cytotoxicity are unknown. Apoptosis of intestinal epithelial cells (IEC) and an increase in IEL numbers are classical signs of intestinal graft-versus-host disease (GVHD), although whether IEL can mediate IEC apoptosis directly in GVHD is unclear. Recent evidence suggests that target epithelial organ injury observed in GVHD is predominantly Fas-mediated; therefore, we investigated the possibility that IEL induce apoptosis of IEC through a Fas-mediated mechanism. Here, we demonstrate that the IEL isolated from normal mice readily display potent Fas ligand (FasL)-mediated killing activity after CD3 stimulation, and that IEC express Fas, suggesting that IEC are potential targets for FasL-mediated killing by IEL. In vitro, IEL isolated from GVHD mice have markedly increased FasL-mediated killing potential and are spontaneously cytolytic toward host-derived tumor cells predominantly through a Fas-mediated pathway. In vivo transfer of IEL isolated from GVHD mice induced significantly more IEC apoptosis in F1 wild-type mice than in Fas-defective F1lpr mice. Thus, these results demonstrate that FasL-mediated death of IEC by IEL is a major mechanism of IEC apoptosis seen in GVHD.

Version history
  • Version 1 (February 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts